The Digital PCR (dPCR) market is projected to expand from US$ 6.97 billion in 2023 to US$ 15.63 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.9% over the period from 2023 to 2031.
The growth of the Digital PCR (dPCR) market can be largely attributed to the rising prevalence of infectious diseases, including HIV, tuberculosis, malaria, and hepatitis. Despite this growth potential, challenges such as the high costs associated with dPCR instruments and the presence of alternative technologies like next-generation sequencing (NGS) may impede market expansion.
In developing nations, PCR methodologies are gaining traction and acceptance. Various PCR technologies, including Reverse Transcriptase PCR (RT-PCR), Real-time PCR, and Digital PCR (dPCR), are being adopted by laboratories based on specific requirements. The Digital PCR (dPCR) technique is particularly favored for its rapid, straightforward, and highly accurate disease screening capabilities. Its growing applications in clinical microbiology, virology, biotechnology, and related fields suggest that the dPCR market in these regions is poised for significant growth opportunities in the coming years. A notable innovation in this field is Droplet Digital PCR (ddPCR), which utilizes water-oil emulsion droplet technology. This method divides the sample into approximately 20,000 droplets, allowing for the amplification of target DNA strands within each droplet. The ddPCR technology then assesses the nucleic acid targets in these individual droplets, offering high precision and absolute quantification of target DNA molecules. This advancement is expected to be a key trend influencing the Digital PCR (dPCR) market.
Component-Based Insights
From a component perspective, the Digital PCR (dPCR) market is segmented into instruments, reagents and consumables, and software and services. In 2023, the reagents and consumables segment captured a substantial share of the market and is anticipated to exhibit the highest CAGR throughout the forecast period. This segment encompasses essential items such as dyes, vials, kits, buffers, probes, enzymes, and panels, all of which are integral to dPCR processes. The increasing emphasis on early disease detection, coupled with the widespread use of consumables and reagents, along with the growing demand for PCR technologies in the healthcare sector, is driving the need for dPCR and thereby supporting the overall growth of the Digital PCR (dPCR) market.
End User-Based Insights
When categorized by end user, the Digital PCR (dPCR) market includes hospitals and diagnostic centers, pharmaceutical and biotech companies, research laboratories and academic institutions, forensic laboratories, and clinical research organizations. The segment comprising hospitals and diagnostic centers held a significant share of the Digital PCR (dPCR) market in 2023 and is projected to achieve the highest CAGR from 2023 to 2031.
To compile the Digital PCR (dPCR) market report, various primary and secondary sources were utilized, including reputable organizations such as the World Health Organization, the US Food and Drug Administration, and the Centers for Disease Control and Prevention. These sources provide valuable insights and data that inform the analysis of market trends and forecasts.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Digital PCR (dPCR) market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Digital PCR (dPCR) market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Digital PCR (dPCR) market - Global Market Analysis
6.1 dPCR - Global Market Overview
6.2 dPCR - Global Market and Forecast to 2031
7. Digital PCR (dPCR) market - Revenue Analysis (USD Million) - By Technology, 2021-2031
7.1 Overview
7.2 Droplet Digital PCR (ddPCR)
7.3 BEAMing Digital PCR
8. Digital PCR (dPCR) market - Revenue Analysis (USD Million) - By Component, 2021-2031
8.1 Overview
8.2 Instruments
8.3 Reagents and Consumables
8.4 Software and Services
9. Digital PCR (dPCR) market - Revenue Analysis (USD Million) - By Application, 2021-2031
9.1 Overview
9.2 Clinical
9.3 Research
9.4 Forensics
10. Digital PCR (dPCR) market - Revenue Analysis (USD Million) - By End User, 2021-2031
10.1 Overview
10.2 Hospitals and Diagnostic Centers
10.3 Pharmaceutical and Biotech Companies
10.4 Research Laboratories and Academic Institutes
10.5 Clinical Research Organization
10.6 Forensic Laboratories
11. Digital PCR (dPCR) market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis
11.1 North America
11.1.1 North America Digital PCR (dPCR) market Overview
11.1.2 North America Digital PCR (dPCR) market Revenue and Forecasts to 2031
11.1.3 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Technology
11.1.4 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Component
11.1.5 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Application
11.1.6 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By End User
11.1.7 North America Digital PCR (dPCR) market Revenue and Forecasts and Analysis - By Countries
11.1.7.1 United States Digital PCR (dPCR) market
11.1.7.1.1 United States Digital PCR (dPCR) market, by Technology
11.1.7.1.2 United States Digital PCR (dPCR) market, by Component
11.1.7.1.3 United States Digital PCR (dPCR) market, by Application
11.1.7.1.4 United States Digital PCR (dPCR) market, by End User
11.1.7.2 Canada Digital PCR (dPCR) market
11.1.7.2.1 Canada Digital PCR (dPCR) market, by Technology
11.1.7.2.2 Canada Digital PCR (dPCR) market, by Component
11.1.7.2.3 Canada Digital PCR (dPCR) market, by Application
11.1.7.2.4 Canada Digital PCR (dPCR) market, by End User
11.1.7.3 Mexico Digital PCR (dPCR) market
11.1.7.3.1 Mexico Digital PCR (dPCR) market, by Technology
11.1.7.3.2 Mexico Digital PCR (dPCR) market, by Component
11.1.7.3.3 Mexico Digital PCR (dPCR) market, by Application
11.1.7.3.4 Mexico Digital PCR (dPCR) market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 Australia
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 South Korea
11.3.6 Rest of Asia-Pacific
11.4 Middle East and Africa
11.4.1 South Africa
11.4.2 Saudi Arabia
11.4.3 U.A.E
11.4.4 Rest of Middle East and Africa
11.5 South and Central America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Rest of South and Central America
12. Industry Landscape
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. Digital PCR (dPCR) market - Key Company Profiles
14.1 Thermo Fisher Scientific, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies
14.2 F. Hoffman-La Roche
14.3 QIAGEN NV
14.4 Akara Bio, Inc.
14.5 Agilent Technologies
14.6 bioM?rieux SA
14.7 Abbott Laboratories
14.8 Merck
14.9 Promega Corporation
14.10 BD
15. Appendix
15.1 Glossary
15.2 About
15.3 Market Intelligence Cloud
NA
NA
LIST OF TABLES
LIST OF FIGURES
The List of Companies - Digital PCR (dPCR) Market
Thermo Fisher Scientific, Inc.
F. Hoffmann-la Roche Ltd
QIAGEN
Akara bio, Inc.
Agilent Technologies, Inc.
Biomerieux SA
Abbott Laboratories
Merck KgaA
Promega Corporation
BD.
